Literature DB >> 25030062

Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.

Mareike Florek1, Emanuela I Sega1, Dennis B Leveson-Gower1, Jeanette Baker1, Antonia M S Müller2, Dominik Schneidawind1, Everett Meyer1, Robert S Negrin1.   

Abstract

Acute graft-versus-host disease (GVHD) is induced by alloreactivity of donor T cells toward host antigens presented on antigen-presenting cells (APCs). Apoptotic cells are capable of inducing tolerance by altering APC maturation. Apoptosis can be induced by extracorporeal photopheresis (ECP). We demonstrate that the use of ECP as a prophylaxis prior to conditioning significantly improves survival (P < .0001) after bone marrow transplantation (BMT) by inhibiting the initiation phase of acute GVHD in a murine BMT model. ECP-treated autologous splenocytes resulted in immune tolerance in the host, including reduced dendritic cell activation with decreased nuclear factor-κB engagement, increased regulatory T-cell (Treg) numbers with enhanced expression of cytolytic T lymphocyte-associated antigen 4, potentiating their suppressive function. The protective effect required host production of interleukin-10 and host Tregs. Conventional T cells that entered this tolerant environment experienced reduced proliferation, as well as a reduction of tissue homing and expression of activation markers. The induction of this tolerant state by ECP was obviated by cotreatment with lipopolysaccharide, suggesting that the inflammatory state of the recipient prior to treatment would play a role in potential clinical translation. The use of prophylactic ECP may provide an alternative and safe method for immunosuppression in the bone marrow transplant setting.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030062      PMCID: PMC4162113          DOI: 10.1182/blood-2014-02-555128

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

1.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

2.  Shifting foci of hematopoiesis during reconstitution from single stem cells.

Authors:  Yu-An Cao; Amy J Wagers; Andreas Beilhack; Joan Dusich; Michael H Bachmann; Robert S Negrin; Irving L Weissman; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

3.  Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance.

Authors:  Wei-Ping Min; Dejun Zhou; Thomas E Ichim; Gill H Strejan; Xiaoping Xia; Jinming Yang; Xuyan Huang; Bertha Garcia; David White; Patrick Dutartre; Anthony M Jevnikar; Robert Zhong
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

4.  What is trogocytosis and what is its purpose?

Authors:  Etienne Joly; Denis Hudrisier
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

5.  A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.

Authors:  K B Miller; T F Roberts; G Chan; D P Schenkein; D Lawrence; K Sprague; G Gorgun; V Relias; H Grodman; A Mahajan; F M Foss
Journal:  Bone Marrow Transplant       Date:  2004-05       Impact factor: 5.483

6.  Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.

Authors:  Ulrich A Duffner; Yoshinobu Maeda; Kenneth R Cooke; Pavan Reddy; Rainer Ordemann; Chen Liu; James L M Ferrara; Takanori Teshima
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

7.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Authors:  Matthias Edinger; Petra Hoffmann; Joerg Ermann; Kathryn Drago; C Garrison Fathman; Samuel Strober; Robert S Negrin
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

8.  The induction of tolerance by dendritic cells that have captured apoptotic cells.

Authors:  R M Steinman; S Turley; I Mellman; K Inaba
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

Review 9.  Differentiation of T regulatory cells by immature dendritic cells.

Authors:  M G Roncarolo; M K Levings; C Traversari
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

Review 10.  Photopheresis: a new therapeutic concept.

Authors:  R L Edelson
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec
View more
  12 in total

1.  Cellular therapy of the host to prevent GVHD.

Authors:  James Ferrara
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

Review 2.  Apoptotic cell-based therapies for promoting transplantation tolerance.

Authors:  Anil Dangi; Shuangjin Yu; Xunrong Luo
Journal:  Curr Opin Organ Transplant       Date:  2018-10       Impact factor: 2.640

Review 3.  Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.

Authors:  Todd V Brennan; Victoria R Rendell; Yiping Yang
Journal:  Front Immunol       Date:  2015-03-16       Impact factor: 7.561

4.  In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells.

Authors:  Holger Budde; Ulrike Berntsch; Joachim Riggert; Tobias J Legler
Journal:  Cent Eur J Immunol       Date:  2017-05-08       Impact factor: 2.085

5.  Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance.

Authors:  Hilit Levy-Barazany; Liat Shachnai-Pinkas; Tsila Zuckerman; Jerry Stein; Galina Rodionov; Alex Saar; Michal Rosenzwaig; Liron Gez; Anastasia Rodin; Nitzan Marelly; Michal Abraham; Inbal Mishalian; Hila Wildbaum; Tamar Katz; Yuval Baar; Shai Yarkoni; Ronit Bakimer-Kleiner; Amnon Peled
Journal:  Bone Marrow Transplant       Date:  2020-05-20       Impact factor: 5.483

6.  Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.

Authors:  Anne S Renteria; John E Levine; James L M Ferrara
Journal:  Expert Opin Orphan Drugs       Date:  2016-04-06       Impact factor: 0.694

Review 7.  Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease.

Authors:  Lukas M Braun; Robert Zeiser
Journal:  Hemasphere       Date:  2021-06-01

8.  Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.

Authors:  Cindy Franklin; Elvir Cesko; Uwe Hillen; Bastian Schilling; Sven Brandau
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

Review 9.  Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma.

Authors:  Dalil Hannani
Journal:  Front Immunol       Date:  2015-07-07       Impact factor: 7.561

Review 10.  Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.

Authors:  Tik Shing Cheung; Giuliana Minani Bertolino; Chiara Giacomini; Martin Bornhäuser; Francesco Dazzi; Antonio Galleu
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.